Editorial - High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients

Eur Rev Med Pharmacol Sci. 2020 May;24(9):5178-5179. doi: 10.26355/eurrev_202005_21214.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Guillain-Barre Syndrome*
  • Humans
  • Immunoglobulins, Intravenous
  • Pandemics
  • Pneumonia, Viral
  • SARS-CoV-2
  • Severe acute respiratory syndrome-related coronavirus*

Substances

  • Immunoglobulins, Intravenous